Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives
This notice solicits applications to demonstrate the feasibility and effectiveness of providing financial incentives to providers to improve the quality of life of children with sickle cell disease (SCD) through increased prescription rates of hydroxyurea.
This initiative is not issued or
funded by the Centers for Medicare and Medicaid Services (CMS).
This initiative is not issued or
funded by the Centers for Medicare and Medicaid Services (CMS).
Agency: Department of Health and Human Services
Office: Office of the Assistant Secretary for Health
Estimated Funding: $2,500,000
Office: Office of the Assistant Secretary for Health
Estimated Funding: $2,500,000
Obtain Full Opportunity Text:
Demonstration to Increase Hydroxyurea Prescribing for Children with Sickle Cell Disease Through Provider Incentives
Additional Information of Eligibility:
• State Governments • County Governments • City or township governments • Special district governments • Independent school districts • Public and State controlled institutions of higher education • Native American tribal governments (Federally recognized) • Public Housing authorities/Indian housing authorities • Native American tribal organizations (other than federally recognized tribal governments) • Nonprofits having 501(c)(3) status with the IRS, other than institutions of higher education • Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education • Private non-profit institutions of higher education • U. S. Territories
Full Opportunity Web Address:
https://www.grantsolutions.gov/gs/preaward/previewPublicAnnouncement.do?id=67220
Contact:
Agency Email Description:
Grants.gov Customer Support
Agency Email:
Date Posted:
2020-07-28
Application Due Date:
Archive Date:
2020-09-26